Insights and Stories on Elanco

Aug. 7, 2019 at 4:35 pm CDT

Reuters — Germany’s Bayer and U.S. drug firm Elanco Animal Health aim to reach an agreement to combine their animal health businesses as soon as next week, Bloomberg reported Wednesday, citing people with knowledge of the matter. Elanco plans to pay for at least a part of the deal with […]

By Reuters

Aug. 5, 2019 at 8:05 pm CDT

Veterinary drugmaker Elanco Animal Health is expanding its space in the swine sector with a deal to buy the Quebec startup behind Coliprotec vaccines. Indianapolis-based Elanco announced Thursday it has paid $78.5 million to buy Prevtec Microbia, which is headquartered in Montreal with facilities in St-Hyacinthe. The Coliprotec line is […]

By GFM Staff

Sep. 20, 2018 at 1:45 pm CDT

Reuters — Eli Lilly unit Elanco Animal Health’s shares jumped as much as 41 per cent on their stock market debut on Thursday, adding to investor enthusiasm for the fast-growing animal healthcare market. Elanco’s shares opened at $32.25 on the New York Stock Exchange, higher than their IPO price of […]

By Aparajita Saxena

Sep. 6, 2018 at 6:38 pm CDT

Reuters — Eli Lilly + Co.’s Elanco Animal Health unit expects its initial public offering to raise up to US$1.45 billion, betting on increased appetite among investors for animal health companies. The IPO of 62.9 million shares is expected to be priced between $20-$23 per unit, with the company having […]

By Ankur Banerjee

Mar. 24, 2016 at 5:20 pm CDT

A new drug to help limit mastitis in dairy cows — and keep a lid on the use of antimicrobials to treat it — has picked up joint approval from Health Canada and the U.S. Food and Drug Administration. The two agencies on Thursday announced “simultaneous” approvals for Elanco Animal […]

By Staff